Concepedia

Maria Hammarberg

MH

Statistics

Publications

5

Citations

149

H-Index

5

Active since

2016

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (France)

AstraZeneca (Netherlands)

Orion Corporation (Finland)

Maria Hammarberg is an author at AstraZeneca (Sweden) specializing in pharmacy, pharmacology, and physiologically based biopharmaceutics modeling.

ORCID

Publications per year

2016–2022

5

Publications

5

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

Alison Margolskee, Adam S. Darwich, Xavier Pépin et al. · European Journal of Pharmaceutical Sciences · 2016 · 67 citations · Full text

, , +16

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes

Adam S. Darwich, Alison Margolskee, Xavier Pépin et al. · European Journal of Pharmaceutical Sciences · 2016 · 45 citations · Full text

, , +17

Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space – Part I: Adults

Xavier Pépin, Maria Hammarberg, Alexandra Mattinson et al. · Pharmaceutical Research · 2022 · 15 citations

, , +14

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects

Renli Teng, Maria Hammarberg, Glenn Carlson et al. · Clinical Drug Investigation · 2017 · 12 citations · Full text

, , +7

Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs

V. Sashi Gopaul, Elsbet Pieterman, P. Hans et al. · European Journal of Pharmaceutical Sciences · 2021 · 10 citations · Full text

, , +9

1–5 of 5